Lycopene and tomato powder supplementation similarly inhibit high-fat diet induced obesity, inflammatory response, and associated metabolic disorders

Molecular Nutrition and Food Research

Volumn 61, Issue 9, 2017, Pages

  Fenni, Soumia ^a,b   Hammou, Habib ^b   Astier, Julien ^a   Bonnet, Lauriane ^a   Karkeni, Esma ^a   Couturier, Charlène ^a   Tourniaire, Franck ^a   Landrier, Jean François ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b UNIVERSITY OF ORAN   (Algeria)

Author keywords

Adipose tissue carotenoids; Inflammation; Insulin sensitivity; Metabolic disease; Obesity; steatosis; Tomato product

Indexed keywords

ANTIINFLAMMATORY AGENT; CAROTENOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYCOPENE;

ADIPOSE TISSUE; ANIMAL; BODY COMPOSITION; C57BL MOUSE; DIETARY SUPPLEMENT; DRUG EFFECT; LIPID DIET; LIPID METABOLISM; MALE; METABOLIC DISORDER; METABOLISM; MOUSE; OBESITY; PHYSIOLOGY; TOMATO;

ADIPOSE TISSUE; ANIMALS; ANTI-INFLAMMATORY AGENTS; BODY COMPOSITION; CAROTENOIDS; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; LIPID METABOLISM; LYCOPERSICON ESCULENTUM; MALE; METABOLIC DISEASES; MICE; MICE, INBRED C57BL; NF-KAPPA B; OBESITY;

EID: 85017592723     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201601083     Document Type: Article

References (62)

1. Gregor, M. F., Hotamisligil, G. S., Inflammatory mechanisms in obesity. Annu. Rev. Immunol. 2011, 29, 415–445.
2. Tourniaire, F., Romier-Crouzet, B., Lee, J. H., Marcotorchino, J. et al., Chemokine expression in inflamed adipose tissue is mainly mediated by NF-kappaB. PLoS One 2013, 8, e66515.
3. Rao, A. V., Ray, M. R., Rao, L. G., Lycopene. Adv. Food Nutr. Res. 2006, 51, 99–164.
4. Palozza, P., Parrone, N., Catalano, A., Simone, R., Tomato lycopene and inflammatory cascade: basic interactions and clinical implications. Curr. Med. Chem. 2010, 17, 2547–2563.
5. Chung, H. Y., Ferreira, A. L., Epstein, S., Paiva, S. A. et al., Site-specific concentrations of carotenoids in adipose tissue: relations with dietary and serum carotenoid concentrations in healthy adults. Am. J. Clin. Nutr. 2009, 90, 533–539.
6. Landrier, J. F., Marcotorchino, J., Tourniaire, F., Lipophilic micronutrients and adipose tissue biology. Nutrients 2012, 4, 1622–1649.
7. Moussa, M., Gouranton, E., Gleize, B., Yazidi, C. E. et al., CD36 is involved in lycopene and lutein uptake by adipocytes and adipose tissue cultures. Mol. Nutr. Food Res. 2011, 55, 578–584.
8. Sy, C., Gleize, B., Dangles, O., Landrier, J. F. et al., Effects of physicochemical properties of carotenoids on their bioaccessibility, intestinal cell uptake, and blood and tissue concentrations. Mol. Nutr. Food Res. 2012, 56, 1385–1397.
9. Sluijs, I., Beulens, J. W., Grobbee, D. E., van der Schouw, Y. T., Dietary carotenoid intake is associated with lower prevalence of metabolic syndrome in middle-aged and elderly men. J. Nutr. 2009, 139, 987–992.
10. Gouranton, E., Thabuis, C., Riollet, C., Malezet-Desmoulins, C. et al., Lycopene inhibits proinflammatory cytokine and chemokine expression in adipose tissue. J. Nutr. Biochem. 2011, 22, 642–648.
11. Marcotorchino, J., Romier, B., Gouranton, E., Riollet, C. et al., Lycopene attenuates LPS-induced TNF-alpha secretion in macrophages and inflammatory markers in adipocytes exposed to macrophage-conditioned media. Mol. Nutr. Food Res. 2012, 56, 725–732.
12. Singh, D. P., Khare, P., Zhu, J., Kondepudi, K. K. et al., A novel cobiotic-based preventive approach against high-fat diet-induced adiposity, nonalcoholic fatty liver and gut derangement in mice. Int. J. Obes. 2016, 40, 487–496.
13. Luvizotto Rde, A., Nascimento, A. F., Imaizumi, E., Pierine, D. T. et al., Lycopene supplementation modulates plasma concentrations and epididymal adipose tissue mRNA of leptin, resistin and IL-6 in diet-induced obese rats. Br. J. Nutr. 2013, 110, 1803–1809.
14. Wang, Y., Ausman, L. M., Greenberg, A. S., Russell, R. M. et al., Dietary lycopene and tomato extract supplementations inhibit nonalcoholic steatohepatitis-promoted hepatocarcinogenesis in rats. Int. J. Cancer 2011, 126, 1788–1796.
15. Ip, B. C., Hu, K. Q., Liu, C., Smith, D. E. et al., Lycopene metabolite, apo-10'-lycopenoic acid, inhibits diethylnitrosamine-initiated, high fat diet-promoted hepatic inflammation and tumorigenesis in mice. Cancer Prev. Res. 2013, 6, 1304–1316.
16. Wang, X. D., Lycopene metabolism and its biological significance. Am. J. Clin. Nutr. 2012, 96, 1214S–1222S.
17. Story, E. N., Kopec, R. E., Schwartz, S. J., Harris, G. K., An update on the health effects of tomato lycopene. Annu. Rev. Food Sci. Technol. 2010, 1, 189–210.
18. Müller, L., Caris-Veyrat, C., Lowe, G., Böhm, V., Lycopene and its antioxidant role in the prevention of cardiovascular diseases-A critical review. Crit. Rev. Food Sci. Nutr. 2016, 56, 1868–1879.
19. Bonet, M. L., Canas, J. A., Ribot, J., Palou, A., Carotenoids and their conversion products in the control of adipocyte function, adiposity and obesity. Arch. Biochem. Biophys. 2015, 572, 112–125.
20. Canene-Adams, K., Campbell, J. K., Zaripheh, S., Jeffery, E. H. et al., The tomato as a functional food. J. Nutr. 2005, 135, 1226–1230.
21. Tourniaire, F., Musinovic, H., Gouranton, E., Astier, J. et al., All-trans retinoic acid induces oxidative phosphorylation and mitochondria biogenesis in adipocytes. J. Lipid Res. 2016, 56, 1100–1109.
22. Stice, C. P., Liu, C., Aizawa, K., Greenberg, A. S. et al., Dietary tomato powder inhibits alcohol-induced hepatic injury by suppressing cytochrome p450 2E1 induction in rodent models. Arch. Biochem. Biophys. 2015, 572, 81–88.
23. Landrier, J. F., Malezet-Desmoulins, C., Reboul, E., Marie Lorec, A. et al., Comparison of different vehicles to study the effect of tocopherols on gene expression in intestinal cells. Free Radic. Res. 2008, 42, 523–530.
24. Livak, K. J., Schmittgen, T. D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25, 402–408.
25. Karkeni, E., Marcotorchino, J., Tourniaire, F., Astier, J. et al., Vitamin D limits chemokine expression in adipocytes and macrophage migration in vitro and in male mice. Endocrinology 2015, 156, 1782–1793.
26. Tornatore, L., Thotakura, A. K., Bennett, J., Moretti, M. et al., The nuclear factor kappa B signaling pathway: integrating metabolism with inflammation. Trends Cell Biol. 2012, 22, 557–566.
27. Lorenz, M., Fechner, M., Kalkowski, J., Fröhlich, K. et al., Effects of lycopene on the initial state of atherosclerosis in New Zealand White (NZW) rabbits. PLoS One 2012, 7, e30808.
28. Ozmen, O., Topsakal, S., Haligur, M., Aydogan, A. et al., Effects of caffeine and lycopene in experimentally induced diabetes mellitus. Pancreas 2016, 45, 579–583.
29. Palozza, P., Catalano, A., Simone, R., Cittadini, A., Lycopene as a guardian of redox signalling. Acta Biochim. Pol. 2012, 59, 21–25.
30. Zou, J., Feng, D., Ling, W. H., Duan, R. D., Lycopene suppresses proinflammatory response in lipopolysaccharide-stimulated macrophages by inhibiting ROS-induced trafficking of TLR4 to lipid raft-like domains. J. Nutr. Biochem. 2012, 24, 1117–1122.
31. Chalasani, N., Liang, T., Alloosh, M., Bell, L. N. et al., Liver injury and fibrosis induced by dietary challenge in the Ossabaw miniature Swine. PLoS One 2012, 10, e0124173.
32. Pan, M. H., Lai, C. S., Tsai, M. L., Ho, C. T., Chemoprevention of nonalcoholic fatty liver disease by dietary natural compounds. Mol. Nutr. Food Res. 2014, 58, 147–171.
33. Bahcecioglu, I. H., Kuzu, N., Metin, K., Ozercan, I. H. et al., Lycopene prevents development of steatohepatitis in experimental nonalcoholic steatohepatitis model induced by high-fat diet. Vet. Med. Int. 2010, 2010, pii: 262179. https://doi.org/10.4061/2010/262179.
34. Chung, J., Koo, K., Lian, F., Hu, K. Q. et al., Apo-10'-lycopenoic acid, a lycopene metabolite, increases sirtuin 1 mRNA and protein levels and decreases hepatic fat accumulation in ob/ob mice. J. Nutr. 2012, 142, 405–410.
35. Bernal, C., Martin-Pozuelo, G., Lozano, A. B., Sevilla, A. et al., Lipid biomarkers and metabolic effects of lycopene from tomato juice on liver of rats with induced hepatic steatosis. J. Nutr. Biochem. 2013, 24, 1870–1881.
36. Melendez-Martinez, A. J., Nascimento, A. F., Wang, Y., Liu, C. et al., Effect of tomato extract supplementation against high-fat diet-induced hepatic lesions. Hepatobiliary Surg. Nutr. 2013, 2, 198–208.
37. Ip, B. C., Wang, X. D., Non-alcoholic steatohepatitis and hepatocellular carcinoma: implications for lycopene intervention. Nutrients 2014, 6, 124–162.
38. Rao, A. V., Rao, L. G., Carotenoids and human health. Pharmacol. Res. 2007, 55, 207–216.
39. Kaulmann, A., Bohn, T., Carotenoids, inflammation, and oxidative stress—implications of cellular signaling pathways and relation to chronic disease prevention. Nutr. Res. 2014, 34, 907–929.
40. Ip, B. C., Liu, C., Lichtenstein, A. H., von Lintig, J. et al., Lycopene and apo-10'-lycopenoic acid have differential mechanisms of protection against hepatic steatosis in beta-carotene-9',10'-oxygenase knockout male mice. J. Nutr. 2015, 145, 268–276.
41. Ford, N. A., Elsen, A. C., Erdman, J. W., Jr., Genetic ablation of carotene oxygenases and consumption of lycopene or tomato powder diets modulate carotenoid and lipid metabolism in mice. Nutr. Res. 2013, 33, 733–742.
42. Tan, H. L., Moran, N. E., Cichon, M. J., Riedl, K. M. et al., beta-Carotene-9',10'-oxygenase status modulates the impact of dietary tomato and lycopene on hepatic nuclear receptor-, stress-, and metabolism-related gene expression in mice. J. Nutr. 2014, 144, 431–439.
43. Zaghini, I., Landrier, J. F., Grober, J., Krief, S. et al., Sterol regulatory element-binding protein-1c is responsible for cholesterol regulation of ileal bile acid-binding protein gene in vivo. Possible involvement of liver-X-receptor. J. Biol. Chem. 2002, 277, 1324–1331.
44. Becard, D., Hainault, I., Azzout-Marniche, D., Bertry-Coussot, L. et al., Adenovirus-mediated overexpression of sterol regulatory element binding protein-1c mimics insulin effects on hepatic gene expression and glucose homeostasis in diabetic mice. Diabetes 2001, 50, 2425–2430.
45. Ameer, F., Scandiuzzi, L., Hasnain, S., Kalbacher, H. et al., De novo lipogenesis in health and disease. Metabolism 2014, 63, 895–902.
46. Kersten, S., Seydoux, J., Peters, J. M., Gonzalez, F. J. et al., Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J. Clin. Invest. 1999, 103, 1489–1498.
47. Poirier, Y., Antonenkov, V. D., Glumoff, T., Hiltunen, J. K., Peroxisomal beta-oxidation—a metabolic pathway with multiple functions. Biochim. Biophys. Acta. 2006, 1763, 1413–1426.
48. Ishizuka, K., Usui, I., Kanatani, Y., Bukhari, A. et al., Chronic tumor necrosis factor-alpha treatment causes insulin resistance via insulin receptor substrate-1 serine phosphorylation and suppressor of cytokine signaling-3 induction in 3T3-L1 adipocytes. Endocrinology 2007, 148, 2994–3003.
49. Eder, K., Baffy, N., Falus, A., Fulop, A. K., The major inflammatory mediator interleukin-6 and obesity. Inflamm. Res. 2009, 58, 727–736.
50. Keophiphath, M., Rouault, C., Divoux, A., Clement, K. et al., CCL5 promotes macrophage recruitment and survival in human adipose tissue. Arterioscler. Thromb. Vasc. Biol. 2009, 30, 39–45.
51. Murdoch, C., Finn, A., Chemokine receptors and their role in inflammation and infectious diseases. Blood 2000, 95, 3032–3043.
52. Viola, A., Luster, A. D., Chemokines and their receptors: drug targets in immunity and inflammation. Annu. Rev. Pharmacol. Toxicol. 2008, 48, 171–197.
53. Fantuzzi, G., Adipose tissue, adipokines, and inflammation. J. Allergy Clin. Immunol. 2005, 115, 911–919; quiz 920.
54. Maffei, M., Barone, I., Scabia, G., Santini, F., The multifaceted haptoglobin in the context of adipose tissue and metabolism. Endocr. Rev. 2016, 37, 403–416.
55. Rabe, K., Lehrke, M., Parhofer, K. G., Broedl, U. C., Adipokines and insulin resistance. Mol. Med. 2008, 14, 741–751.
56. Lee, M. J., Wu, Y., Fried, S. K., Adipose tissue remodeling in pathophysiology of obesity. Curr. Opin. Clin. Nutr. Metab. Care 2010, 13, 371–376.
57. Li, Y. F., Chang, Y. Y., Huang, H. C., Wu, Y. C. et al., Tomato juice supplementation in young women reduces inflammatory adipokine levels independently of body fat reduction. Nutrition 2015, 31, 691–696.
58. Limtrakul, P., Yodkeeree, S., Pitchakarn, P., Punfa, W., Suppression of inflammatory responses by black rice extract in RAW 264.7 macrophage cells via downregulation of NF-kB and AP-1 signaling pathways. Asian Pac J. Cancer Prev. 2015, 16, 4277–4283.
59. Kim, G. Y., Kim, J. H., Ahn, S. C., Lee, H. J. et al., Lycopene suppresses the lipopolysaccharide-induced phenotypic and functional maturation of murine dendritic cells through inhibition of mitogen-activated protein kinases and nuclear factor-kappaB. Immunology 2004, 113, 203–211.
60. Hadad, N., Levy, R., The synergistic anti-inflammatory effects of lycopene, lutein, beta-carotene, and carnosic acid combinations via redox-based inhibition of NF-kappaB signaling. Free Radic. Biol. Med. 2012, 53, 1381–1391.
61. Boileau, T. W., Liao, Z., Kim, S., Lemeshow, S. et al., Prostate carcinogenesis in N-methyl-N-nitrosourea (NMU)-testosterone-treated rats fed tomato powder, lycopene, or energy-restricted diets. J. Natl. Cancer Inst. 2003, 95, 1578–1586.
62. Burton-Freeman, B., Sesso, H. D., Whole food versus supplement: comparing the clinical evidence of tomato intake and lycopene supplementation on cardiovascular risk factors. Adv. Nutr. 2014, 5, 457–485.